Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

Concepts (373)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
43
2024
590
8.650
Why?
Chronic Pain
17
2024
178
5.870
Why?
Opioid-Related Disorders
17
2024
400
4.060
Why?
Drug Overdose
11
2024
163
3.880
Why?
Medicaid
23
2021
264
2.720
Why?
Drug Prescriptions
15
2024
102
2.630
Why?
Tramadol
3
2024
30
2.390
Why?
Alcoholism
4
2022
239
2.380
Why?
Antipsychotic Agents
10
2018
235
1.940
Why?
Retrospective Studies
45
2025
6578
1.800
Why?
Anticoagulants
7
2025
267
1.730
Why?
Adult
59
2025
14139
1.720
Why?
Middle Aged
59
2025
13014
1.670
Why?
United States
53
2024
5182
1.660
Why?
Humans
112
2025
52336
1.580
Why?
Osteoarthritis, Knee
3
2017
97
1.480
Why?
Pain
11
2022
360
1.470
Why?
Health Care Costs
10
2022
175
1.350
Why?
Young Adult
29
2025
4319
1.330
Why?
Female
74
2025
28105
1.330
Why?
Adolescent
38
2024
6692
1.310
Why?
Aged
44
2025
10109
1.300
Why?
Male
70
2025
26696
1.290
Why?
Atrial Fibrillation
4
2016
200
1.230
Why?
Viscosupplements
3
2017
14
1.230
Why?
Asthma
4
2017
316
1.210
Why?
Hyaluronic Acid
3
2017
38
1.210
Why?
Mental Disorders
7
2025
428
1.170
Why?
Medication Adherence
6
2016
133
1.150
Why?
Emergency Service, Hospital
6
2016
521
1.120
Why?
Schizophrenia
5
2009
254
1.090
Why?
Cross-Over Studies
2
2025
238
1.080
Why?
Cohort Studies
17
2024
1532
1.050
Why?
Arthroplasty, Replacement, Knee
4
2017
289
1.040
Why?
Analgesics, Non-Narcotic
3
2012
117
1.030
Why?
Substance-Related Disorders
5
2021
609
1.010
Why?
Acetaminophen
4
2015
279
1.010
Why?
Warfarin
4
2016
83
0.990
Why?
Venous Thromboembolism
2
2025
75
0.980
Why?
Patient Compliance
6
2009
230
0.980
Why?
Veterans
10
2024
581
0.940
Why?
Psychotropic Drugs
1
2025
77
0.900
Why?
Psychotherapy
1
2025
113
0.870
Why?
Suicide
1
2025
85
0.850
Why?
Prescription Drugs
6
2014
41
0.840
Why?
Cost-Benefit Analysis
5
2020
269
0.830
Why?
Insurance, Health
7
2020
131
0.800
Why?
Risk Factors
15
2025
3872
0.780
Why?
Attention Deficit Disorder with Hyperactivity
1
2023
178
0.750
Why?
Neck Pain
2
2021
10
0.750
Why?
Back Pain
2
2021
39
0.740
Why?
Arkansas
14
2024
2028
0.730
Why?
Drug Utilization
11
2017
77
0.730
Why?
Central Nervous System Stimulants
1
2023
206
0.720
Why?
Arthralgia
1
2021
44
0.710
Why?
Hospitalization
6
2016
732
0.710
Why?
Professional-Patient Relations
1
2021
47
0.710
Why?
Insurance, Pharmaceutical Services
2
2019
25
0.700
Why?
Decision Support Techniques
3
2016
70
0.700
Why?
Stroke
3
2016
509
0.690
Why?
Logistic Models
8
2016
920
0.660
Why?
Narcotic Antagonists
2
2024
139
0.660
Why?
Naloxone
1
2020
79
0.640
Why?
Breast Neoplasms
4
2023
1206
0.630
Why?
Hydrocodone
3
2024
20
0.620
Why?
Oxycodone
3
2024
26
0.620
Why?
Legislation, Drug
1
2019
18
0.610
Why?
Contraception
1
2019
29
0.600
Why?
Proton Pump Inhibitors
2
2016
86
0.600
Why?
Adrenal Cortex Hormones
2
2017
114
0.570
Why?
Follow-Up Studies
8
2024
2268
0.560
Why?
Guidelines as Topic
1
2018
110
0.550
Why?
Mammography
1
2018
97
0.550
Why?
Buprenorphine
3
2024
151
0.550
Why?
Practice Guidelines as Topic
3
2017
487
0.540
Why?
Histamine H2 Antagonists
1
2016
26
0.530
Why?
Peptic Ulcer
1
2016
14
0.530
Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.510
Why?
Education, Pharmacy, Graduate
1
2016
19
0.500
Why?
Pyridones
1
2016
36
0.500
Why?
Risk
4
2020
313
0.490
Why?
Inappropriate Prescribing
1
2016
23
0.490
Why?
Safety-Based Drug Withdrawals
1
2015
7
0.490
Why?
Dextropropoxyphene
1
2015
6
0.490
Why?
Insurance Claim Review
5
2010
40
0.490
Why?
Health Expenditures
3
2011
73
0.480
Why?
Tobacco Use Cessation
1
2015
10
0.480
Why?
For-Profit Insurance Plans
1
2015
2
0.480
Why?
Databases, Factual
11
2022
706
0.480
Why?
Brain Ischemia
2
2016
161
0.470
Why?
Pyrazoles
1
2016
114
0.470
Why?
Mass Screening
1
2018
357
0.460
Why?
Quinolines
1
2015
44
0.460
Why?
Time Factors
9
2018
2957
0.460
Why?
Acetates
1
2015
52
0.460
Why?
Opiate Substitution Treatment
3
2024
102
0.450
Why?
Stress, Psychological
1
2016
273
0.450
Why?
Diabetic Neuropathies
1
2015
56
0.450
Why?
Anticonvulsants
2
2006
133
0.450
Why?
Insurance Claim Reporting
2
2011
11
0.450
Why?
Low Back Pain
2
2025
31
0.440
Why?
Critical Illness
1
2016
292
0.440
Why?
Controlled Substances
2
2024
7
0.440
Why?
Curriculum
2
2018
399
0.430
Why?
Pain Management
1
2015
178
0.430
Why?
Palliative Care
1
2016
214
0.420
Why?
Tobacco Products
1
2015
127
0.420
Why?
Aged, 80 and over
13
2023
3391
0.420
Why?
Injections, Intra-Articular
3
2017
38
0.410
Why?
Computers, Handheld
1
2013
23
0.410
Why?
Prescription Drug Misuse
3
2024
33
0.410
Why?
Neoplasms
1
2023
1305
0.410
Why?
Evidence-Based Medicine
3
2014
261
0.400
Why?
United States Department of Veterans Affairs
5
2024
293
0.390
Why?
Neuralgia
2
2023
43
0.390
Why?
Quality-Adjusted Life Years
3
2020
67
0.390
Why?
Age Factors
6
2018
1127
0.380
Why?
Benzodiazepines
3
2024
71
0.380
Why?
Cross-Sectional Studies
6
2022
1676
0.370
Why?
Health Knowledge, Attitudes, Practice
1
2015
509
0.360
Why?
Case-Control Studies
7
2023
1201
0.350
Why?
Community Pharmacy Services
3
2020
66
0.350
Why?
Medicare
6
2023
274
0.340
Why?
Health Personnel
1
2013
252
0.330
Why?
Kidney Failure, Chronic
2
2022
210
0.320
Why?
Employment
2
2015
93
0.320
Why?
Age Distribution
5
2018
174
0.310
Why?
Motor Vehicles
1
2009
14
0.310
Why?
Antidepressive Agents
2
2009
177
0.310
Why?
Automobile Driving
1
2009
27
0.310
Why?
Propensity Score
3
2022
155
0.300
Why?
Medication Errors
1
2009
25
0.300
Why?
Pharmacists
3
2019
141
0.300
Why?
Hemorrhage
3
2023
209
0.290
Why?
Prevalence
5
2018
1007
0.290
Why?
Cost of Illness
3
2013
120
0.290
Why?
Physicians, Primary Care
2
2018
46
0.290
Why?
Pain Measurement
6
2021
257
0.280
Why?
Health Resources
2
2012
72
0.280
Why?
College Admission Test
2
2018
13
0.280
Why?
Antimanic Agents
1
2007
14
0.270
Why?
School Admission Criteria
2
2018
35
0.270
Why?
Schools, Pharmacy
2
2018
55
0.270
Why?
Markov Chains
2
2020
30
0.260
Why?
Georgia
6
2006
42
0.260
Why?
Pharmaceutical Services
2
2018
52
0.260
Why?
Child
10
2019
7157
0.260
Why?
Hypoglycemic Agents
1
2008
210
0.260
Why?
Constipation
1
2006
37
0.260
Why?
Orthopedic Procedures
2
2017
71
0.260
Why?
Overweight
1
2009
224
0.260
Why?
Postoperative Complications
2
2025
1066
0.260
Why?
Multivariate Analysis
4
2017
590
0.250
Why?
Least-Squares Analysis
4
2011
44
0.250
Why?
Platelet Aggregation Inhibitors
2
2021
181
0.250
Why?
United States Food and Drug Administration
4
2011
98
0.250
Why?
Knee Joint
2
2017
165
0.250
Why?
Students, Pharmacy
2
2018
123
0.240
Why?
Odds Ratio
4
2020
558
0.240
Why?
Risperidone
2
2010
25
0.230
Why?
Colectomy
1
2025
35
0.230
Why?
North Carolina
5
2011
56
0.230
Why?
Polypharmacy
1
2004
15
0.230
Why?
Drug Costs
2
2020
39
0.220
Why?
General Practitioners
1
2023
4
0.220
Why?
Severity of Illness Index
3
2017
1021
0.220
Why?
Patient Selection
1
2025
259
0.210
Why?
Haloperidol
1
2003
46
0.210
Why?
Renal Dialysis
2
2022
179
0.210
Why?
Direct Service Costs
1
2003
5
0.200
Why?
Motivation
1
2025
281
0.200
Why?
Irritable Bowel Syndrome
1
2003
17
0.200
Why?
Aftercare
1
2023
71
0.200
Why?
Dose-Response Relationship, Drug
5
2014
1377
0.200
Why?
Premedication
1
2002
18
0.200
Why?
Health Services Needs and Demand
1
2004
159
0.190
Why?
Diabetes Mellitus, Type 2
1
2008
561
0.190
Why?
Common Cold
1
2002
5
0.190
Why?
Bronchitis
1
2002
10
0.190
Why?
Advisory Committees
3
2018
71
0.190
Why?
Thromboembolism
1
2002
50
0.190
Why?
Proportional Hazards Models
4
2017
443
0.190
Why?
Accidents
1
2021
21
0.190
Why?
Respiratory Insufficiency
1
2023
114
0.180
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
170
0.180
Why?
Depressive Disorder, Major
2
2020
148
0.180
Why?
Forecasting
3
2009
154
0.180
Why?
Colorectal Neoplasms
1
2025
295
0.180
Why?
Ambulatory Care Facilities
1
2002
124
0.180
Why?
Mental Health Services
1
2004
212
0.180
Why?
Respiratory Tract Infections
1
2002
81
0.170
Why?
Patient Discharge
1
2023
317
0.170
Why?
Delivery of Health Care
2
2021
323
0.170
Why?
Interprofessional Relations
2
2018
91
0.170
Why?
Afghan Campaign 2001-
2
2018
40
0.170
Why?
Regression Analysis
5
2013
401
0.170
Why?
Administration, Oral
2
2016
451
0.170
Why?
Obesity
1
2009
1162
0.170
Why?
Decision Making
5
2018
282
0.170
Why?
Administration, Intranasal
1
2020
31
0.170
Why?
Cardiovascular Diseases
2
2018
486
0.160
Why?
Brain Neoplasms
1
2023
290
0.160
Why?
Economics, Pharmaceutical
2
2009
6
0.160
Why?
Selection Bias
2
2009
15
0.160
Why?
Social Media
1
2022
117
0.160
Why?
Comparative Effectiveness Research
2
2009
47
0.160
Why?
Preventive Health Services
1
2020
52
0.160
Why?
Coronary Restenosis
1
2019
32
0.150
Why?
Guideline Adherence
3
2025
137
0.150
Why?
Child, Preschool
5
2011
4030
0.150
Why?
Drug Administration Schedule
3
2011
372
0.150
Why?
Sepsis
1
2021
229
0.150
Why?
Insurance Coverage
1
2020
115
0.150
Why?
Health Care Surveys
2
2011
177
0.150
Why?
Public Health Surveillance
1
2018
18
0.150
Why?
Thiazoles
2
2016
55
0.150
Why?
Sleep Deprivation
1
2018
19
0.150
Why?
Papillomavirus Vaccines
1
2019
69
0.140
Why?
Pharmacies
1
2019
60
0.140
Why?
Physicians
1
2021
240
0.140
Why?
Chronic Disease
5
2011
583
0.140
Why?
Metabolic Diseases
1
2018
47
0.140
Why?
Veterans Health
2
2014
64
0.140
Why?
Molecular Weight
1
2017
82
0.140
Why?
Acute Pain
1
2017
11
0.140
Why?
Lung Neoplasms
1
2023
636
0.140
Why?
Coronary Vessels
1
2019
169
0.130
Why?
Papillomavirus Infections
1
2019
172
0.130
Why?
Coronary Angiography
1
2019
366
0.130
Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
Why?
Educational Measurement
1
2018
197
0.130
Why?
Treatment Outcome
7
2010
5407
0.130
Why?
Eosinophils
1
2017
44
0.130
Why?
Monte Carlo Method
1
2016
88
0.130
Why?
Early Detection of Cancer
1
2018
183
0.130
Why?
Chilaiditi Syndrome
1
2015
1
0.130
Why?
Education, Pharmacy
1
2018
150
0.120
Why?
Anti-Bacterial Agents
1
2002
801
0.120
Why?
Incidental Findings
1
2015
43
0.120
Why?
India
1
2015
62
0.120
Why?
Health Services Accessibility
1
2020
437
0.120
Why?
Geriatrics
1
2016
47
0.120
Why?
Sex Distribution
1
2015
137
0.120
Why?
Health Policy
3
2011
158
0.120
Why?
Sulfides
1
2015
29
0.120
Why?
Models, Theoretical
1
2016
182
0.120
Why?
Cyclopropanes
1
2015
27
0.120
Why?
Pyridines
1
2016
133
0.120
Why?
Income
1
2015
103
0.120
Why?
Thrombosis
1
2018
253
0.120
Why?
Coronary Artery Disease
1
2019
297
0.120
Why?
Renal Insufficiency, Chronic
1
2018
187
0.110
Why?
Anti-Asthmatic Agents
1
2015
33
0.110
Why?
Sarcopenia
1
2015
98
0.110
Why?
Societies, Medical
1
2016
200
0.110
Why?
Self Report
1
2016
208
0.110
Why?
Long-Term Care
3
2012
51
0.110
Why?
Educational Status
1
2015
227
0.110
Why?
Enoxaparin
2
2025
30
0.110
Why?
Disease Progression
1
2017
870
0.110
Why?
California
2
2004
90
0.110
Why?
Comorbidity
5
2017
624
0.110
Why?
Health Literacy
1
2015
132
0.100
Why?
Health Behavior
1
2015
257
0.100
Why?
Prescriptions
2
2011
11
0.100
Why?
Monitoring, Physiologic
1
2013
122
0.100
Why?
Sensitivity and Specificity
1
2015
879
0.100
Why?
Risk Assessment
2
2015
1323
0.100
Why?
Drug Therapy, Combination
2
2004
395
0.090
Why?
Infant
3
2011
3684
0.090
Why?
Managed Care Programs
1
2012
36
0.090
Why?
Ticlopidine
1
2012
56
0.090
Why?
Predictive Value of Tests
2
2019
943
0.090
Why?
Randomized Controlled Trials as Topic
2
2025
594
0.090
Why?
Deductibles and Coinsurance
1
2011
2
0.090
Why?
Hypertension, Pulmonary
1
2012
118
0.080
Why?
Body Mass Index
2
2013
689
0.080
Why?
Calibration
1
2009
57
0.080
Why?
International Classification of Diseases
1
2009
67
0.080
Why?
Clozapine
2
2010
25
0.080
Why?
Analysis of Variance
1
2010
555
0.080
Why?
Reference Values
1
2009
313
0.080
Why?
Treatment Refusal
1
2009
35
0.080
Why?
Carbamazepine
1
2007
13
0.070
Why?
Lithium Compounds
1
2007
12
0.070
Why?
Alendronate
1
2007
24
0.070
Why?
Mental Health
1
2010
240
0.070
Why?
Valproic Acid
1
2007
35
0.070
Why?
Fractures, Spontaneous
1
2007
15
0.070
Why?
Internationality
3
2014
43
0.070
Why?
Osteoporosis, Postmenopausal
1
2007
29
0.070
Why?
Chemotherapy, Adjuvant
1
2007
124
0.070
Why?
Affect
1
2007
104
0.070
Why?
Drug Labeling
1
2006
11
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Data Collection
2
2009
289
0.060
Why?
Adrenergic beta-Agonists
1
2005
42
0.060
Why?
Self Disclosure
1
2005
12
0.060
Why?
Australia
1
2025
90
0.060
Why?
Multicenter Studies as Topic
1
2025
104
0.060
Why?
Drug Interactions
2
2018
205
0.060
Why?
Depression
1
2009
600
0.060
Why?
Factor Analysis, Statistical
1
2004
86
0.060
Why?
Eligibility Determination
1
2004
21
0.060
Why?
Urban Population
1
2005
162
0.060
Why?
Health Surveys
2
2018
238
0.060
Why?
Prescription Fees
1
2004
14
0.050
Why?
Length of Stay
1
2007
659
0.050
Why?
Algorithms
1
2007
668
0.050
Why?
Laparoscopy
1
2025
180
0.050
Why?
Data Interpretation, Statistical
3
2009
164
0.050
Why?
MEDLINE
1
2002
8
0.050
Why?
SEER Program
1
2023
103
0.050
Why?
Prospective Studies
1
2008
2428
0.050
Why?
Cognition Disorders
1
2003
196
0.050
Why?
Antidepressive Agents, Second-Generation
1
2002
27
0.050
Why?
Quality of Life
2
2023
868
0.050
Why?
Neuropsychological Tests
1
2003
333
0.050
Why?
Analgesics
1
2023
107
0.050
Why?
Pharmacy
2
2018
55
0.050
Why?
Gastrointestinal Hemorrhage
1
2022
89
0.050
Why?
Longitudinal Studies
2
2014
741
0.040
Why?
Patient Protection and Affordable Care Act
1
2020
52
0.040
Why?
Needs Assessment
1
2020
139
0.040
Why?
Myocardial Revascularization
1
2019
21
0.040
Why?
Ohio
1
2019
45
0.040
Why?
Quality of Health Care
1
2020
187
0.040
Why?
Incidence
2
2014
1059
0.040
Why?
Pharmacoepidemiology
1
2017
8
0.030
Why?
Universities
1
2018
175
0.030
Why?
Research Design
2
2014
354
0.030
Why?
Vaccination
1
2019
297
0.030
Why?
Pilot Projects
1
2019
719
0.030
Why?
Communication
1
2018
257
0.030
Why?
Qualitative Research
1
2018
362
0.030
Why?
Electronic Health Records
1
2018
269
0.030
Why?
Attitude of Health Personnel
1
2018
360
0.030
Why?
Ischemic Attack, Transient
1
2013
57
0.030
Why?
Survival Analysis
1
2014
671
0.020
Why?
Lipids
1
2013
157
0.020
Why?
Linear Models
1
2013
286
0.020
Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.020
Why?
Stress Disorders, Post-Traumatic
1
2017
401
0.020
Why?
Diagnostic Tests, Routine
1
2012
31
0.020
Why?
Cost Control
1
2011
13
0.020
Why?
Acute Coronary Syndrome
1
2012
80
0.020
Why?
Blood Pressure
1
2013
534
0.020
Why?
Blood Glucose
1
2013
471
0.020
Why?
Reproducibility of Results
2
2005
1214
0.020
Why?
Dibenzothiazepines
1
2010
10
0.020
Why?
Adolescent Behavior
1
2011
106
0.020
Why?
Hypnotics and Sedatives
1
2010
72
0.020
Why?
Off-Label Use
1
2010
24
0.020
Why?
Observation
1
2009
8
0.020
Why?
Epidemiologic Methods
1
2009
46
0.020
Why?
Causality
1
2009
52
0.020
Why?
Diabetes Mellitus
1
2013
315
0.020
Why?
Mood Disorders
1
2009
59
0.020
Why?
Quinolones
1
2010
50
0.020
Why?
Anxiety Disorders
1
2009
130
0.020
Why?
Piperazines
1
2010
117
0.020
Why?
ROC Curve
1
2009
251
0.020
Why?
Headache
1
2008
76
0.020
Why?
Sex Factors
1
2009
727
0.020
Why?
Confidence Intervals
1
2007
158
0.020
Why?
Probability
1
2007
171
0.020
Why?
Drug Utilization Review
1
2005
22
0.010
Why?
Drug Monitoring
1
2005
83
0.010
Why?
Bone Density
1
2007
399
0.010
Why?
Registries
1
2007
580
0.010
Why?
Health Maintenance Organizations
1
2002
16
0.010
Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
Why?
Costs and Cost Analysis
1
2002
95
0.010
Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description